Skip NavigationSkip to Content
Return Return to Search Results

Inhibition of HIV-1 replication by amphotericin B methyl ester - Selection for resistant variants

  1. Author:
    Waheed, A. A.
    Ablan, S. D.
    Mankowski, M. K.
    Cummins, J. E.
    Ptak, R. G.
    Schaffner, C. P.
    Freed, E. O.

  2. Author Address

    NCI, Virus Cell Interact Sect, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA. So Res Inst, Infect Dis Res Dept, Frederick, MD 21701 USA. Rutgers State Univ, Waksman Inst, Dept Microbiol & Biochem, New Brunswick, NJ 08903 USA.;Freed, EO, NCI, Virus Cell Interact Sect, HIV Drug Resistance Program, NIH, Bldg 535,Rm 108, Frederick, MD 21702 USA.;efreed@mail.nih.gov
    1. Year: 2006
    2. Date: Sep
  2. Journal: Journal of Biological Chemistry
    1. 281
    2. 39
    3. Pages: 28699-28711
  4. Type of Article: Article
  5. ISSN: 0021-9258
  1. Abstract:

    Membrane cholesterol plays an important role in human immunodeficiency virus type 1 (HIV-1) particle production and infectivity. Here, we have investigated the target and mechanism of action of a cholesterol-binding compound, the polyene antifungal antibiotic amphotericin B methyl ester (AME). We found that AME potently inhibited the replication of a highly divergent panel of HIV-1 isolates in various T-cell lines and primary cells irrespective of clade or target cell tropism. The defects in HIV-1 replication caused by AME were due to profoundly impaired viral infectivity as well as a defect in viral particle production. To elucidate further the mechanism of action of AME, we selected for and characterized AME-resistant HIV-1 variants. Mutations responsible for AME resistance mapped to a highly conserved and functionally important endocytosis motif in the cytoplasmic tail of the transmembrane glycoprotein gp41. Interestingly, truncation of the gp41 cytoplasmic tail in the context of either HIV-1 or rhesus macaque simian immunodeficiency virus also conferred resistance to AME. The infectivity of HIV-1 virions bearing murine leukemia virus or vesicular stomatitis virus glycoproteins was unaffected by AME. Our data define the target and mechanism of action of AME and provide support for the concept that cholesterol-binding compounds should be pursued as antiretroviral drugs to disrupt HIV-1 replication.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1074/jbc.M603609200
  3. View record in Web of Science®
  4. WOS: 000240680500023

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel